FDA Drug Application (200221) for OLANZAPINE by JUBILANT GENERICS

Back to FDA Applications sponsored by JUBILANT GENERICS

Application Number200221
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOLANZAPINE
Active IngredientOLANZAPINE

Active IngredientCount
List of drugs with Active Ingredient OLANZAPINE5


Back to FDA Applications sponsored by JUBILANT GENERICS